Monday, 12th October 30th Australian and New Zealand Bone and Mineral Society Annual Scientific Meeting 2020

• PTH resistance syndrome: genetics and epigenetics - Harald Jueppner

• Dairy supplementation reduces fractures and falls in institutionalised older adults: a cluster-randomised controlled trial - Sandra Iuliano
• Bone geometry is altered by follistatin-induced muscle growth in adult male mice - Audrey S Chan
• Interaction between osteocyte SOCS3-dependent signaling and the bone marrow microenvironment maintains cortical bone integrity - Tsuyoshi Isojima
• Subject characteristics and changes in bone mineral density after transitioning from denosumab (DMab) to alendronate (ALN) in the Denosumab Adherence Preference Satisfaction (DAPS) Study - Peter R Ebeling
• An essential physiological role for MCT8 in bone in male mice - Victoria D Leitch

• Multi-targeting DKK1 and LRP6 prevents myeloma-induced bone disease - Marija K Simic
• Single-cell mapping of bone identifies key intercellular interactions within the endosteal bone microenvironment - James T Smith
• Osteal macrophage contributions to post-menopausal osteoporosis bone pathology - Lena Batoon
• MCP-1 inhibition prevents breast cancer-induced bone loss - Bridie S Mulholland
• Hip structural analysis and incident fractures in a cohort of women - Kara B Anderson
• The effect of denosumab on post-fracture mortality risk in the 45 and Up study - Dunia Alarkawi
• Heterogeneity in Microstructural Deterioration Following Spinal Cord Injury Reflects Site-Specificity of Mechano-transduction - Ali Ghasem-Zadeh
• Fractures in T2DM independently predicted by insulin use and vascular complications (FIELD study) - Angela Sheu

• Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers - Kara L Holloway-Kew
• Bone Compartment Characteristics in Patients with Atypical Femoral Fractures on 3D Dual X-Ray Absorptiometry (DXA) - Albert S Kim
• DXA-derived Trabecular Bone Score and Hip Structural Analysis Parameters in Patients with Type 1 Diabetes Mellitus undergoing Simultaneous Pancreas Kidney Transplantation - Jasna Aleksova
• The Use of Denosumab in Central Giant Cell Granuloma: 5-year Institutional Experience - Yoon Ji Jina Rhou
• A global natural history study of fibrodysplasia ossificans progressiva (FOP): 12-month outcomes - Shane Patella
• The first 4 years of an osteoporosis re-fracture prevention (ORP) service at Royal North Shore Hospital (RNSH): Treatment and re-fracture rates among ORP attendees and non-attendees:  - Lillias Nairn
• Can circulating Wnt antagonist DKK1 alter bone mass by endocrine signalling? - Ya Xiao
• Molecular imaging at the multi-scale discloses novel regulators of matrix organisation during bone pathology - Aikta Sharma
• Treatment with a chimeric long-acting CSF1 molecule enhances fracture healing of healthy and osteoporotic bones - Lena Batoon
• Neutrophils are dispensable for neurogenic heterotopic ossification development following spinal cord injury - Hsu-Wen HWT Tseng
• Chondrocyte glucocorticoid receptor deletion attenuates cartilage damage in murine osteoarthritis - Eugenie Macfarlane
• Sclerostin Antibody Does Not Affect Endpoints Related to Atheroprogression, Plaque Calcification, or Inflammation in Murine Models of Atherosclerosis - Rogely Boyce

Panel Members:

1. David Scott - NHMRC EL2 Deakin University (formerly Monash University)

2. Brya Matthews - Sir Charles Hercus Fellowship - University of Auckland, NZ

3. John Kemp - NHMRC EL1 - University of Queensland

4. Allison Pettit - ARC Future Fellowship - University of Queensland

5. Lana Williams - NHMRC EL2 - Deakin University

• Myth-busting the NHMRC Investigator Grant scheme - David Scott

• Bone health in obesity and weight loss - Jackie Center
• Prescribing exercise for osteoporosis - Belinda Beck
• Bone health in young women with primary or secondary hypogonadism - Bronwyn Stuckey